Scientific Content
- Real-world data on the abuse potential of medications for the treatment of insomnia
- Efficacy and safety of daridorexant in women with insomnia disorder during menopausal transition: a subgroup analysis
- Efficacy and safety of daridorexant in patients with chronic insomnia disorder and comorbid nocturia
- Effect of daridorexant on wakefulness throughout the night and morning sleepiness in patients with insomnia disorder
- Effect of daridorexant on wakefulness throughout the night: Post hoc analysis of a randomised, double-blind, active reference (zolpidem) study in patients with insomnia disorder
- The impact of insomnia disorder on the night and the day: analysis of polysomnography and subjective parameters from a large clinical trial database
- The impact of insomnia disorder on the night and the day in older and younger adults
- The impact of insomnia disorder on the night and the day in males and females
Symposium
World Sleep Society Congress 2025
Managing insomnia disorder in patients with neurological and psychiatric comorbidities
September 5–10, 2025, Singapore
David Neubauer (Chair)
Johns Hopkins School of Medicine
Baltimore, United States
Lu Lin (Co-Chair)
Peking Univerity
Beijing, China
.jpg)
Laura Palagini
University of Pisa
Pisa, Italy
Atul Khullar
University of Alberta and Med Sleep
Edmonton, Canada
Claudio Liguori
University of Rome Tor Vergata
Rome , Italy
